Radiomics signature of brain metastasis: prediction of EGFR mutation status

ConclusionsWe developed a T2-FLAIR radiomics signature that can be used as a noninvasive auxiliary tool for predicting EGFR mutation status in lung adenocarcinoma, which is helpful to guide therapeutic strategies.Key Points• MR-based radiomics signature of brain metastasis may help predict EGFR mutation status in lung adenocarcinoma, especially using T2-FLAIR.• Nine radiomics features extracted from T2-FLAIR sequence strongly correlate with EGFR mutation status.• Radiomics features reflect tumor heterogeneity through potential changes in tissue morphology caused by EGFR mutation.
Source: European Radiology - Category: Radiology Source Type: research